Similarly, in two of the three CYSLTR2 mutant primary uveal melanomas from the TCGA cohort preferential expression of the mutant allele was observed, while in all cases the wild-type allele was still present (Fig. 3b). The gene discussed is CYSLTR2; the disease is uveal melanoma.